Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 496-503

  McCarthy, Philip L ^a   Hahn, Theresa ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BORONIC ACID DERIVATIVE; BORTEZOMIB; DRUG DERIVATIVE; LENALIDOMIDE; MELPHALAN; MYELOABLATIVE AGENT; PYRAZINE DERIVATIVE; THALIDOMIDE;

AUTOGRAFT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MULTIPLE MYELOMA; REMISSION; REVIEW; TIME;

ANGIOGENESIS INHIBITORS; AUTOGRAFTS; BORONIC ACIDS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MELPHALAN; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; PYRAZINES; REMISSION INDUCTION; THALIDOMIDE; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 84903528713     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.496     Document Type: Review

References (0)